Some women report minor changes during their first month of therapy, but these are typically temporary
Answer: The core benefit is durable appetite control without stimulants, which supports steady weight loss, easier portion control, and, when combined with a GLP-1 medication, weight loss outcomes that rival much more aggressive interventions in trials
The dual action of GLP-1 on both insulin and glucagon regulation has driven the development of pharmacological GLP-1RAs with extended half-lives, such as semaglutide, liraglutide, and tirzepatide [57]
The combination of ferroptosis inducers with conventional therapy has shown favorable tolerability and minimal toxicity in preclinical models [188]
[Abstract] Direct interaction between CAPNS1 and CRBN was assessed by incubating purified GST, GST-CRBN, or GST-neurogranin proteins with glutathione agarose for 3 hours